I. Corporate Profile & Statutory Registry Records
| Official Chinese Name | 盈永投資有限公司 | Official English Name | GAIN FUTURE INVESTMENTS LIMITED |
|---|---|---|---|
| Company Reg No. (CRN) | 2508157 | Business Reg No. (BRN / UBI) | 67480324 HK Unique Business ID · US IRS Form W-8BEN-E Foreign TIN |
| Incorporation Date | 2017-03-24 | Company Category | Private company limited by shares |
| Current Legal Status | Live | Statutory Filing Cycle | 2027-03-24(2026 Return Filed) |
| Registered Office Address | 26/F, BLOCK II, WYLER CENTRE, 200 TAI LIN PAI ROAD, KWAI TSING DISTRICT, NEW TERRITORIES, HONG KONGWyler Centre · Kwai Chung · 244 Co-Located Entities → | ||
|---|---|---|---|
| Significant Controllers (SCR) | Statutorily maintained. To penetrate ultimate beneficial owners (UBO) and holding structures, please apply for a Due Diligence Report. | ||
II. Companies Registry Document Retrieval(Annual Return NAR1 & ND2A Filings)
| Document Name | Action |
|---|---|
NAR1 Annual Return (2026) (English)Latest Shareholders & Directors | |
ND2A Notice of Change of Company Secretary and Director (English) | |
ND2A Notice of Change of Company Secretary and Director (English) | |
NAR1 Annual Return (2025) (English) | |
ND2A Notice of Change of Company Secretary and Director (English) | |
NAR1 Annual Return (2024) (English) | |
BRN_REF Reference Document for Business Registration Number as UBI | |
NAR1 Annual Return (2023) (English) | |
M1 Notice of Particulars of Specified Charge / Mortgage (English) | |
M1 Notice of Particulars of Specified Charge / Mortgage (English) |
III. Commercial Due Diligence & Regulatory Risk Screening
IV. Corporate Statutory Dossier & Legal Status FAQ
Q1
How many times has GAIN FUTURE INVESTMENTS LIMITED changed its Hong Kong registered office address (Form NR1)?
Current Hong Kong registered address on file: [26/F, BLOCK II, WYLER CENTRE, 200 TAI LIN PAI ROAD, KWAI TSING DISTRICT, NEW TERRITORIES, HONG KONG]. Official registry dossiers document 1 historical registered office address change filing(s) (Form NR1).